Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia

Louise C. Kenny, Leslie W. Brown, Paloma Ortea, Robin Tuytten, Douglas B. Kell*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

57 Downloads (Pure)

Abstract

Ergothioneine, an antioxidant nutraceutical mainly at present derived from the dietary intake of mushrooms, has been suggested as a preventive for pre-eclampsia (PE). We analysed early pregnancy samples from a cohort of 432 first time mothers as part of the Screening for Endpoints in Pregnancy (SCOPE, European branch) project to determine the concentration of ergothioneine in their plasma. There was a weak association between the ergothioneine levels and maternal age but none for BMI. Of these 432 women, 97 went on to develop pre-term (23) or term (74) PE. If a threshold was set at the 90th percentile of the reference range in the control population (≥462 ng/ml), only one of these 97 women (1%) developed PE, versus 96/397 (24.2%) whose ergothioneine level was below this threshold. One possible interpretation of these findings, consistent with previous experiments in a reduced uterine perfusion model in rats, is that ergothioneine may indeed prove protective against PE in humans. An intervention study of some kind now seems warranted.

Original languageEnglish
Article numberBSR20230160
JournalBioscience Reports
Volume43
Issue number7
Number of pages9
ISSN0144-8463
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia'. Together they form a unique fingerprint.

Cite this